Ku­ra flash­es pos­i­tive HRAS da­ta on once-failed J&J drug

Troy Wil­son was work­ing with J&J on their KRAS in­hibitor and pe­ri­od­i­cal­ly thumb­ing through their pub­li­ca­tions when he spot­ted an old drug called tip­i­farnib that …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER